Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
- Conditions
- Fallopian Tube CancerOvarian CancerStage III Ovarian CancerStage IV Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma
- Interventions
- Other: Prehabilitation
- First Posted Date
- 2019-12-19
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 22
- Registration Number
- NCT04204811
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Chemoembolization for Lung Tumors
- Conditions
- Lung MetastasesPleural MetastasesMediastinal MetastasesEndobronchial Metastases
- Interventions
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT04200417
- Locations
- 🇺🇸
Memoral Sloan Kettering Monmouth (Consent only), Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Commack (Consent Only), Commack, New York, United States
🇺🇸Memoral Sloan Kettering Westchester (Consent only), Harrison, New York, United States
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- Conditions
- Small Cell Lung CancerSmall Cell Lung Carcinoma
- Interventions
- Drug: SC16.56, Phase I, Cohort 2Drug: SC16.56, Phase IIDrug: SC16.56, Phase I, Cohort 3
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 53
- Registration Number
- NCT04199741
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases
- Conditions
- Leptomeningeal MetastasisBrain Metastases
- Interventions
- Radiation: whole brain radiation therapy radiation
- First Posted Date
- 2019-12-10
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT04192981
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
🇺🇸University of Washington (Data Collection AND Data Analysis), Seattle, Washington, United States
🇺🇸Memorial Sloan Kettering Cancer Center (All protocol activities), New York, New York, United States
Bacillus Calmette-Guérin (BCG) and Gemcitabine in People With High-Grade Non-Muscle Invasive Bladder Cancer That Came Back After BCG Treatment
- Conditions
- Non-Muscle Invasive Bladder Cancer (NMIBC)
- Interventions
- Drug: Bacillus Calmette-Guérin (BCG)
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 54
- Registration Number
- NCT04179162
- Locations
- 🇺🇸
Hartford Healthcare (Data Collection), Hartford, Connecticut, United States
🇺🇸Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients
- Conditions
- Breast Cancer Stage IBreast CancerBreast Cancer Stage IIIBreast Cancer Stage II
- Interventions
- Device: PAXMAN Scalp Cooler
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 34
- Registration Number
- NCT04180579
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
- Conditions
- Multiple MyelomaPlasmacytoma of BonePlasmacytoma
- Interventions
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT04174196
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Communication Training for Caregivers In Advanced Care Planning
- Conditions
- Advanced Care PlanningPrimary Malignant Brain Tumors
- Interventions
- Other: QuestionnairesOther: Enhanced usual careOther: Communication training Part 1 (no longer recruiting)Other: Communication training Part II
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 49
- Registration Number
- NCT04171895
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
- Conditions
- Brain CancerBrain Tumor
- Interventions
- Diagnostic Test: PET/MR with [18F]PARPi
- First Posted Date
- 2019-11-21
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT04173104
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses
- Conditions
- BleedingCancer
- First Posted Date
- 2019-11-20
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 93
- Registration Number
- NCT04170231
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States